fbpx

NEURO-VIT

thiamine, pyridoxine,cyanocobalamine

Film-coated tablets 100 mg+200 mg+0,2 mg

ATC A11DB

Prescription-only medicine

POSOLOGY AND METHOD OF ADMINISTRATION

The recommended dose is one film-coated tablet, once a day. In single cases the dose may be increased to one film-coated tablets, three times daily.

Duration of treatment is determined by the doctor. After a period of 4 weeks, the doctor has to decide for the dose or continuation of treatment.

NEURO-VIT film-coated tablets should be swallowed whole without chewing, with some liquids with or after a meal.

Children and adolescents

Due to their high active substance content NEURO-VIT film-coated tablets must not be used in children (age of 12 years).


Medicine’s information on this web page is only a short description of its characteristics. Do not take them as recommendations for self-treatment of your health condition.

You must inform your physician and pharmacist and follow their recommendations before you use the medicine for treatment. Always read carefully the patient information leaflet.

COMPOSITION

Each film-coated tablet contains 100 mg thiamine hydrochloride, 200 mg pyridoxine hydrochloride and 0.2 mg cyanocobalamin.

THERAPEUTIC INDICATIONS

EURO-VIT film-coated tablets are combination of vitamins B1, B6 and B12.

NEURO-VIT film coated tablets are indicated as adjuvant treatment for neuritis and neuralgia (neuropathy), eg: trigeminal neuralgia, intercostal neuralgia, and ischialgia, lumbar syndrome, cervical syndrome, shoulder-hand syndrome, radicular neuritis due to a degenerative disease of the spine, facial paralysis.

CONTRAINDICATIONS

• Known hypersensitivity to benzodiazepines and any other ingredients in diazepam tablets.
• Phobic or obsessional states; chronic psychosis (paradoxical reactions may occur).
• Acute pulmonary insufficiency; respiratory depression (ventilatory failure may be exacerbated).
• Myasthenia gravis (condition may be exacerbated).
• Sleep apnoea (condition may be exacerbated).
• Severe hepatic insufficiency (elimination half-life of diazepam may be prolonged).
• Acute porphyria.
• Diazepam should not be used as monotherapy in patients with depression or those with anxiety and depression as suicide may be precipitated in such patients.


PACKAGING

Box of 30 coated tablets of 2 mg in a blister package.
Box of 30 coated tablets of 5 mg in a blister package.
Box of 30 coated tablets of 10 mg in a blister package.